About Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company's segments include Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on over five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Drug Manufacturers - Major
- Sub-Industry: Pharmaceuticals
- Exchange: NYSE
- Symbol: JNJ
- CUSIP: 47816010
- Previous Close: $118.08
- 50 Day Moving Average: $114.45
- 200 Day Moving Average: $117.02
- 52-Week Range: $2,720,531,000.00 - $102.97
- Trailing P/E Ratio: 20.04
- Foreward P/E Ratio: 16.11
- P/E Growth: 2.86
- Market Cap: $323.36B
- Outstanding Shares: 2,720,531,000
- Beta: 0.74
- Net Margins: 22.78%
- Return on Equity: 25.61%
- Return on Assets: 13.40%
Companies Related to Johnson & Johnson:
- Debt-to-Equity Ratio: 0.32%
- Current Ratio: 2.73%
- Quick Ratio: 2.36%
What is Johnson & Johnson's stock symbol?
Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol "JNJ."
How often does Johnson & Johnson pay dividends? What is the dividend yield for Johnson & Johnson?
Johnson & Johnson declared a quarterly dividend on Tuesday, January 3rd. Shareholders of record on Tuesday, February 28th will be given a dividend of $0.80 per share on Tuesday, March 14th. This represents a $3.20 annualized dividend and a yield of 2.69%. The ex-dividend date of this dividend is Friday, February 24th.
Where is Johnson & Johnson's stock going? Where will Johnson & Johnson's stock price be in 2017?
19 equities research analysts have issued 1-year target prices for Johnson & Johnson's shares. Their forecasts range from $94.00 to $145.00. On average, they anticipate Johnson & Johnson's share price to reach $122.40 in the next year.
When will Johnson & Johnson announce their earnings?
Johnson & Johnson is scheduled to release their next quarterly earnings announcement on Tuesday, April, 18th 2017.
What are analysts saying about Johnson & Johnson stock?
Here are some recent quotes from research analysts about Johnson & Johnson stock:
According to Zacks Investment Research, "J&J’s Pharma segment is performing well despite challenges like generic competition for a few products, potential biosimilar competition and lower HCV revenues. While Pfizer’s launch of biosimilar Remicade creates some uncertainty regarding the segment’s sales growth in 2017, we believe that the impact may be manageable. Contribution from new as well as core products, share buybacks and the restructuring initiative should help drive results. Estimates have remained mostly stable lately ahead of the Q4 earnings results. J&J has a positive record of earnings surprises in recent quarters. J&J's shares have surpassed that of large-cap pharma industry in 2016. However, headwinds persist in the form of generics and biosimilar competition and pricing pressure." (1/9/2017)
Jefferies Group LLC analysts commented, "With biosimilars and generics expected to drag the next few years, we expect JNJ will continue look to M&A to augment growth. Whilst this should ultimately drive better growth, we believe that investors will not reward the shares for this initially." (1/5/2017)
Morgan Stanley analysts commented, "We need more evidence of execution to raise our numbers, but in a more bullish scenario the Consumer margin opportunity and growth acceleration in both segments could be worth ~9% upside to our current 2020 EPS estimate, and represent ~13% upside to J&J’s SOTP given the higher consumer multiple." (5/19/2016)
Who owns Johnson & Johnson stock?
Johnson & Johnson's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include State Street Corp (5.64%), FMR LLC (1.21%), Barrow Hanley Mewhinney & Strauss LLC (0.44%), Franklin Resources Inc. (0.28%), Dimensional Fund Advisors LP (0.24%) and AQR Capital Management LLC (0.23%). Company insiders that own Johnson & Johnson stock include Charles Prince, Dominic J Caruso, Gary J Pruden, Paulus Stoffels, Peter Fasolo and Ronald A Kapusta.
Who sold Johnson & Johnson stock? Who is selling Johnson & Johnson stock?
Johnson & Johnson's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Aberdeen Asset Management PLC UK, Federated Investors Inc. PA, Tweedy Browne Co. LLC, TCW Group Inc., Barrow Hanley Mewhinney & Strauss LLC, Westwood Holdings Group Inc. and RidgeWorth Capital Management LLC. Company insiders that have sold Johnson & Johnson stock in the last year include Dominic J Caruso, Gary J Pruden, Paulus Stoffels and Ronald A Kapusta.
Who bought Johnson & Johnson stock? Who is buying Johnson & Johnson stock?
Johnson & Johnson's stock was bought by a variety of institutional investors in the last quarter, including State Street Corp, Russell Investments Group Ltd., Asset Management One Co. Ltd., DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main, Renaissance Technologies LLC, Elkfork Partners LLC, Equity Investment Corp Acquisition Inc and Genovese Burford & Brothers Wealth & Retirement Plan Management LLC.
How do I buy Johnson & Johnson stock?
Shares of Johnson & Johnson can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Johnson & Johnson stock cost?
One share of Johnson & Johnson stock can currently be purchased for approximately $118.86.